Nearly 25% of eligible #cancer patients did not receive targeted therapies for their diseases, according to a study.
Watson Health's @NLevitan1 looks at why – and the complexities of clinician decision-making in #PrecisionOncology.
Read his blog: https://ibm.co/3h2fCyM .pic.twitter.com/qP9m0wlBJl
11:00 PM - 19 Jul 2020
0 replies
6 retweets
13 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.